8-K
filed October 18, 2023, 7:59 PM ET
CIK 0001538210
other material
confidence high
sentiment neutral
materiality 0.70
NexImmune announces 1-for-25 reverse stock split effective Oct 18, 2023 to regain Nasdaq compliance
NexImmune, Inc.
- Reverse stock split at 1-for-25 ratio effective after market close on Oct 18, 2023.
- Shares outstanding reduced from ~26.5M to ~1.06M; authorized shares unchanged at 100M.
- Stockholders approved split at special meeting on Oct 17, 2023 (13.8M for, 344K against).
- Split is intended to regain minimum bid price compliance on Nasdaq Capital Market.
- Fractional shares cashed out at closing price on Oct 18; CUSIP changes to 65344D 208.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
NexImmune, Inc.: Reverse stock split at 1-for-25 ratio, effective after close of trading on October 18, 2023 (effective 2023-10-18).
- Change
- charter amendment
- Effective
- 2023-10-18
Exact text from the filing
On October 18, 2023, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to effect a one-time reverse stock split of the Company’s common stock, at a ratio of 1-for-25 (the “Reverse Stock Split”). The Reverse Stock Split was effective at 5 p.m. Eastern Time, after the close of trading on the Nasdaq Capital Market, on October 18, 2023 (the “Effective Time”).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
NexImmune, Inc. shareholders approved Approval of adjournment of the special meeting to solicit additional proxies if necessary. at the 2023-10-17 meeting.
- Outcome
- passed
- Meeting
- 2023-10-17
Exact text from the filing
Votes For Votes Against Votes Abstained 13,899,330 286,293 88,853
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
NexImmune, Inc. shareholders approved Approval of amendment to certificate of incorporation to effect a reverse stock split at a ratio of not less than 1-for-4 and not more than 1-for-50, with exact ratio set by board. at the 2023-10-17 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-10-17
Exact text from the filing
Votes For Votes Against Votes Abstained 13,838,206 344,220 92,050
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.